Edwards Lifesciences v Meril (CFI, ORD_56918/2024, 15 November 2024)
| Date | 15 November 2024 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_56354/2024 · ORD_56918/2024 |
| Parties | Meril Gmbh, Meril Life Sciences Pvt Ltd. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 15 November 2024 (UPC_CFI_15/2023, ACT_459987/2023, ORD_56918/2024), the Munich Local Division (Judges Zigann, presiding and rapporteur, Kokke, Pichlmaier and technically qualified judge Wilhelm), in Edwards Lifesciences’ action for infringement of EP 3 646 825 against Meril GmbH and Meril Life Sciences, rejected the defendants’ request, filed on 16 October 2024 after the hearing of 24 September, that the Court ask the European Commission about possible abuse of dominance investigations (Art. 102 TFEU) concerning the claimant, and that they be allowed to file further pleadings or have the hearing reopened. The order confirms that once the proceedings have closed, further pleadings are in principle ruled out.
Question
Can a party, after the written procedure, the interim procedure and the oral hearing have closed, obtain an inquiry addressed to the Commission and leave to file further pleadings?
Decision
The Court may disregard late steps and arguments (Rule 9.2), and further pleadings require a reasoned request before the judge-rapporteur closes the written procedure (Rule 36). The written and interim procedures and the hearing had ended, and no post-hearing submissions had been allowed. The request therefore fell outside any open procedural stage. Granting it would have jeopardised the decision date set for 15 November 2024. Moreover, the Court had already asked for an update at the hearing. The claimant had confirmed that nothing had changed and that the Commission had opened no formal investigation, and the defendants alleged no new fact.
Key points for practice
- Practical point: competition law matters that may bear on the case must be raised and documented before the hearing closes, a late request will be disregarded.
Provisions applied
- Agreement on a Unified Patent Court
- Arts 52(1) and 73(2)(b)
- Rules of Procedure
- Rules 9.2, 36, 102.1, 220.2 and 224.1(b)
- Case law cited
- Relied on by the claimant: NanoString v President and Fellows of Harvard College, Munich Central Division, 25 July 2024, Carrier v BITZER Electronics, Court of Appeal, 28 May 2024.
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantMeril Gmbh45 decisions in the corpusFollow this party
- claimantMeril Life Sciences Pvt Ltd.32 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- La demande, formée après l'audience, tendant à interroger la Commission européenne et à déposer de nouvelles écritures est rejetée comme tardive et inutile.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 646 825mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Carrier v BITZER Electronics (CoA, 28 May 2024) cited in this record
- NanoString v President and Fellows of Harvard College (CFI, 25 July 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 646 825A system comprising a prosthetic valve and a delivery catheter recorded proprietor: Edwards Lifesciences Corp | Mentioned in the analysis (role not qualified) Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.